Feature Article

Reappraisal of Cardiovascular Risk Factors in Patients With Chronic Myeloproliferative Neoplasms

Abstract: Cardiovascular (CV) risk factors are important contributors to thrombotic risk in the general population and in patients with chronic myeloproliferative neoplasms (MPNs). However, the role […]

Feature Article

The Use of Positron Emission Tomography Imaging to Guide Radiation Therapy

Abstract: Positron emission tomography (PET)-based biologic radiation planning has the potential to improve tumor control by improving the accuracy of radiation delivery, allow for rational adaptive […]

Letter From the Editor

Letter From the Editor: Doctors Without Boundaries

I was on vacation, it was 10 pm, and we were on our way home from dinner when I noticed that my cell phone had shut off. […]

Advances in Drug Development

The Impact of Financial Toxicity on Cancer Care

H&O What is financial toxicity, and how does it impact cancer therapy? JP Financial toxicity is a term used to describe the burdens, barriers, and distress […]

Prostate Cancer In Focus

Overcoming Immune Evasion in Advanced Prostate Cancer

H&O Why do some patients with prostate cancer respond to immune checkpoint inhibitors (ICIs), whereas others do not? AA Several clinical trials with ICIs, either alone […]

Advances in LLM

Mosunetuzumab, the First Bispecific Approved for Follicular Lymphoma

H&O What is mosunetuzumab (Lunsumio, Genentech) and how does it work? LEB Mosunetuzumab is a bispecific antibody-based T-cell engager with 2 binding sites. Unlike conventional monoclonal […]